跳至主要内容
临床试验/NCT05433974
NCT05433974Unknown不适用

Pre-therapeutic Analysis of the Individual Radiosensitivity of Cancer Patients in Luxembourg (APRI-Lux): Prospective National Interventional Study With Minimal Risk

Centre Francois Baclesse, Luxembourg0 个研究点目标入组 200 人开始时间: 2022年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
200
主要终点
Validation of RadioDtect test on early radiation-induced toxicity

研究概览

简要总结

Pre-therapeutic analysis of the individual radiosensitivity of cancer patients in Luxembourg

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patient over 18 years old
  • •Patient with an indication for curative radiotherapy
  • •Patient having given his signed written informed consent before any specific procedure of the protocol.

排除标准

  • •Patient with a contraindication to radiotherapy
  • •Patient with an indication for palliative radiotherapy
  • •Patient with a history of radiotherapy in the area where the cancer is located
  • •Patient unable to submit to the medical follow-up of the trial for geographical, social or psychological reasons.

研究组 & 干预措施

Radiosensitivity

Other

Patient who agree to participate in this research study will have blood sample collected in order to perform the RadioDtect test.

干预措施: Blood sample collection (Biological)

结局指标

主要结局

Validation of RadioDtect test on early radiation-induced toxicity

时间窗: 3 months

prospectively validate the predictive capacities of the RadioDtect individual radiosensitivity blood test on early radiation-induced toxicity. The validation will be based on ATM protein assay and rate of acute toxicities of grade ≥ 2 to 3 months according to NCI-CTCAE v4.03 criteria

次要结局

  • Validation of RadioDtect test on delayed radiation-induced toxicity(12 months)

研究者

发起方
Centre Francois Baclesse, Luxembourg
申办方类型
Other
责任方
Sponsor

相似试验